Assessment of relation among emotional status, pulmonary function test, exercise performance, and quality of life in patients with COPD;KOAH'li olgularda depresyon durumu, solunum fonksiyon testi, egzersiz performansi ve yaşam kalitesi arasindaki ilişkinin deǧerlendirilmesi

Tuberkuloz ve Toraks

Volumn 57, Issue 2, 2009, Pages 169-176

  Ulubay, Gaye ^a,b   Sarinç Ulaşli, Sevinç ^a   Akinci, Berna ^a   Görek, Asli ^a   Akçay, Şule ^a  

^a BASKENT UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Beck's depression inventory; COPD; Exercise performance; SF 36

Indexed keywords

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; BECK DEPRESSION INVENTORY; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; EMOTION; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INTERVENTION STUDY; LUNG FUNCTION; LUNG FUNCTION TEST; MALE; MENTAL HEALTH; QUALITY OF LIFE; SHORT FORM 36; WALKING;

AGED; EXERCISE; EXERCISE TEST; FEMALE; HUMANS; MALE; MENTAL HEALTH; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRES; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE;

EID: 68249139921     PISSN: 04941373     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, managementof chronic obstructive pulmonary disease. NHLBI/WHOWorkshop Report 2006. www.goldcopd.com/workshop/ index.html. Date last updated: November 2006.
2. O'Donnell DE, Revill S, Webb K. Dynamic hyperinflation and exercise intolerance in COPD. Am J Respir Crit Care Med 2001; 164: 770-777
3. O'Donnell DE, Laveneziana P. Dyspnea and activity limitation in COPD: Mechanical factors. COPD 2007; 4: 225-236 (Pubitemid 47345897)
4. Kunik ME, Roundy K, Veazey C, et al. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest 2004; 127: 1205-1211 (Pubitemid 46224282)
5. Aydin IO, Ulusahin A. Depression, anxiety comorbidity, and disability in tuberculosis and chronic obstructive pulmonary disease patients: Applicability of the GHQ-12. Gen Hosp Psychiatry 2001; 23: 77-83. (Pubitemid 32335577)
6. Cazzola M, MacNee W, Martinez FJ, et al. ATS/ERS Task Force. Outcomes for COPD pharmacological trials: From lung function to biomarkers. Eur Respir J 2008; 31: 416-469
7. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF. European Respiratory Society. Standardized lung function testing. Lung volumes and forced ventilatory flows. 1993 update. Eur Respir J 1993; 6: 5-40.
8. Macintyre N, Crapo RO, Viegi G, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005; 26: 720-735 (Pubitemid 41448672)
9. ATS Statement: Guidelines for the Six-Minute Walk Test. Am J Respir Crit Care Med 2002; 166: 111-117
10. nd ed. New York: Oxford University Press, 1996: 446.
11. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473.
12. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561.
13. Celli BR, Cole CG, Marin JM, et al. The body mass index, airflow obstruction dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 1005-1012 (Pubitemid 38269277)
14. Mahler DA, Mackowiak JI. Evaluation of the short form 36 item questionnaire to measure health related quality of life patients with COPD. Chest 1995; 107: 1585-1589
15. Spencer S, Calverley PMA, Burger PS, Jones PW. On behalf of the ISOLDE study group. Health status deterioration in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care 2001; 163: 122-128
16. Hajiro T, Nishimura K, Tsukino M, et al. A comparision of the level of dyspnea vs disease severity in indicating the health related quality of life with COPD. Chest 1999; 116: 1632-1637 (Pubitemid 30012705)
17. Soyyiǧit Ş, Erk M, Güler N, Kiliç G. Kronik obstrüktif akciǧer hastaliǧinda yaşam kalitesinin belirlenmesinde SF- 36 saǧlik taramasinin deǧeri. Tuberk Toraks 2006; 54: 259-266
18. Agusti AG, Noguera A, Sauleda J, et al. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 2003; 21: 347-360 (Pubitemid 36204553)
19. O'Donnell DE. Exercise limitation and clinical exercise testing in chronic obstructive pulmonary disease. In: Weissman IM, Zeballos RJ (eds). Cardiovascular and Respiratory System Responses and Limitations to Exercise. Clinical Exercise Testing. Basel: Karger AG, 2002: 138-158
20. Sarpkaya Ü, Tuna H, Tabakoǧlu E, Altiay G. Kronik obstruktif akciǧer hastaliǧinda solunum kaslari egzersizlerinin ve aerobik egzersiz programinin yaşam kalitesi üzerine etkileri. Türk Fiz Tip Rehab Derg 2005; 51: 14-18 (Pubitemid 40613189)
21. Eiser N, West C, Evans S, et al. Effects of psychotherapy in moderately severe COPD: A pilot study. Eur Respir J 1997; 10: 1581-1584 (Pubitemid 27311076)
22. DiMarco F, Verga M, Reggente M, et al. Anxiety and depression in COPD patients: The roles of gender and disease severity. Respir Med 2006; 100: 1767-1774 (Pubitemid 44283757)
23. Kömürcüoǧlu B, Bahoǧlu M, Öztuna I ve ark. KOAH'li erkek olgularda depresyon. Toraks Dergisi 2000; 1: 31-37
24. Kunik ME, Veazey C, Cully JA, et al. COPD education and cognitive behavioral therapy group treatment for clinically significant symptoms of depression and anxiety in COPD patients: A randomized controlled trial. Psychol Med 2007; 1-12.